Literature DB >> 27528709

Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care.

Renske C Bosman1, Klaas M Huijbregts2, Peter Fm Verhaak3, Henricus G Ruhé4, Harm Wj van Marwijk5, Anton Jlm van Balkom6, Neeltje M Batelaan6.   

Abstract

BACKGROUND: Antidepressant use is often prolonged in patients with anxiety and/or depressive disorder(s) compared with recommendations in treatment guidelines to discontinue after sustained remission. AIM: To unravel the motivations of patients and GPs causing long-term antidepressant use and to gain insight into possibilities to prevent unnecessary long-term use. DESIGN AND
SETTING: Qualitative study using semi-structured, in-depth interviews with patients and GPs in the Netherlands.
METHOD: Patients with anxiety and/or depressive disorder(s) (n = 38) and GPs (n = 26) were interviewed. Innovatively, the interplay between patients and their GPs was also investigated by means of patient-GP dyads (n = 20).
RESULTS: The motives and barriers of patients and GPs to continue or discontinue antidepressants were related to the availability of supportive guidance during discontinuation, the personal circumstances of the patient, and considerations of the patient or GP. Importantly, dyads indicated a large variation in policies of general practices around long-term use and continuation or discontinuation of antidepressants. Dyads further indicated that patients and GPs seemed unaware of each other's (mismatching) expectations regarding responsibility to initiate discussing continuation or discontinuation.
CONCLUSION: Although motives and barriers to antidepressant continuation or discontinuation were related to the same themes for patients and GPs, dyads indicated discrepancies between them. Discussion between patients and GPs about antidepressant use and continuation or discontinuation may help clarify mutual expectations and opinions. Agreements between a patient and their GP can be included in a patient-tailored treatment plan. © British Journal of General Practice 2016.

Entities:  

Keywords:  antidepressants; anxiety disorder; continuation; depressive disorder; discontinuation; general practitioners; long-term use; patient perspective

Mesh:

Substances:

Year:  2016        PMID: 27528709      PMCID: PMC5033307          DOI: 10.3399/bjgp16X686641

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  24 in total

1.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

2.  National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2014-02       Impact factor: 4.384

3.  Long-term prescribing of antidepressants in the older population: a qualitative study.

Authors:  Rebecca Dickinson; Peter Knapp; Allan O House; Vandana Dimri; Arnold Zermansky; Duncan Petty; John Holmes; David K Raynor
Journal:  Br J Gen Pract       Date:  2010-04       Impact factor: 5.386

4.  Trajectories of functioning after remission from anxiety disorders: 2-year course and outcome predictors.

Authors:  S C Iancu; N M Batelaan; M B M Zweekhorst; J F G Bunders; D J Veltman; B W J H Penninx; A J L M van Balkom
Journal:  Psychol Med       Date:  2013-05-10       Impact factor: 7.723

Review 5.  Guideline recommendations for long-term treatment of depression with antidepressants in primary care--a critical review.

Authors:  Ellen Piek; Klaas van der Meer; Willem A Nolen
Journal:  Eur J Gen Pract       Date:  2010-06       Impact factor: 1.904

6.  What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study.

Authors:  Gilles Ambresin; Victoria Palmer; Konstancja Densley; Christopher Dowrick; Gail Gilchrist; Jane M Gunn
Journal:  J Affect Disord       Date:  2015-02-02       Impact factor: 4.839

7.  Cost of disorders of the brain in Europe 2010.

Authors:  Anders Gustavsson; Mikael Svensson; Frank Jacobi; Christer Allgulander; Jordi Alonso; Ettore Beghi; Richard Dodel; Mattias Ekman; Carlo Faravelli; Laura Fratiglioni; Brenda Gannon; David Hilton Jones; Poul Jennum; Albena Jordanova; Linus Jönsson; Korinna Karampampa; Martin Knapp; Gisela Kobelt; Tobias Kurth; Roselind Lieb; Mattias Linde; Christina Ljungcrantz; Andreas Maercker; Beatrice Melin; Massimo Moscarelli; Amir Musayev; Fiona Norwood; Martin Preisig; Maura Pugliatti; Juergen Rehm; Luis Salvador-Carulla; Brigitte Schlehofer; Roland Simon; Hans-Christoph Steinhausen; Lars Jacob Stovner; Jean-Michel Vallat; Peter Van den Bergh; Peter Van den Bergh; Jim van Os; Pieter Vos; Weili Xu; Hans-Ulrich Wittchen; Bengt Jönsson; Jes Olesen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09-15       Impact factor: 4.600

8.  Antidepressant use in persons aged 12 and over: United States, 2005-2008.

Authors:  Laura A Pratt; Debra J Brody; Qiuping Gu
Journal:  NCHS Data Brief       Date:  2011-10

9.  Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study.

Authors:  Chris F Johnson; Hector J Macdonald; Pauline Atkinson; Alasdair I Buchanan; Noreen Downes; Nadine Dougall
Journal:  Br J Gen Pract       Date:  2012-11       Impact factor: 5.386

10.  Side effects of antidepressants during long-term use in a naturalistic setting.

Authors:  Pierre M Bet; Jacqueline G Hugtenburg; Brenda W J H Penninx; Witte J G Hoogendijk
Journal:  Eur Neuropsychopharmacol       Date:  2013-05-30       Impact factor: 4.600

View more
  15 in total

1.  Predicting and preventing relapse of depression in primary care.

Authors:  Andrew S Moriarty; Joanne Castleton; Simon Gilbody; Dean McMillan; Shehzad Ali; Richard D Riley; Carolyn A Chew-Graham
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386

2.  The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.

Authors:  Anne Guy; Marion Brown; Stevie Lewis; Mark Horowitz
Journal:  Ther Adv Psychopharmacol       Date:  2020-11-09

3.  Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care.

Authors:  Carolien Wentink; Marloes J Huijbers; Peter Lbj Lucassen; Annoek van der Gouw; Cornelis Kramers; Jan Spijker; Anne Em Speckens
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386

Review 4.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10

5.  The GET READY relapse prevention programme for anxiety and depression: a mixed-methods study protocol.

Authors:  Esther Krijnen-de Bruin; Anna D T Muntingh; Adriaan W Hoogendoorn; Annemieke van Straten; Neeltje M Batelaan; Otto R Maarsingh; Anton J L M van Balkom; Berno van Meijel
Journal:  BMC Psychiatry       Date:  2019-02-11       Impact factor: 3.630

6.  Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators.

Authors:  Rhona Eveleigh; Anne Speckens; Chris van Weel; Richard Oude Voshaar; Peter Lucassen
Journal:  Ther Adv Psychopharmacol       Date:  2019-09-03

7.  Helping people discontinue long-term antidepressants: views of health professionals in UK primary care.

Authors:  Hannah M Bowers; Samantha J Williams; Adam W A Geraghty; Emma Maund; Wendy O'brien; Geraldine Leydon; Carl R May; Tony Kendrick
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

8.  Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies.

Authors:  Alice Tickell; Richard Byng; Catherine Crane; Felix Gradinger; Rachel Hayes; James Robson; Jessica Cardy; Alice Weaver; Nicola Morant; Willem Kuyken
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

Review 9.  Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.

Authors:  Neeltje M Batelaan; Renske C Bosman; Anna Muntingh; Willemijn D Scholten; Klaas M Huijbregts; Anton J L M van Balkom
Journal:  BMJ       Date:  2017-09-13

10.  Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015.

Authors:  Tessa Magnée; Derek P de Beurs; Francois G Schellevis; Peter F Verhaak
Journal:  Scand J Prim Health Care       Date:  2018-01-17       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.